IL11 and breast carcinoma: Notably, studies have identified miR-204, miR-211, and miR-379 as inhibitors of TGF-β-induced IL-11 production in bone metastatic breast cancer cells; these miRNAs directly target IL-11 expression by binding to its 3′UTR (Pollari et al., 2012).